Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Anaerobe|June 30, 2019
Antibiotic use and duration in association with Clostridioides difficile infection in a tertiary academic medical center: A retrospective case-control studyAbrar K Thabit, Christy A Varugehese, Alexander R Levine
Journal of Taibah University Medical Sciences|November 18, 2022
Appropriateness of choice and duration of surgical antibiotic prophylaxis and the incidence of surgical site infections: A prospective studyAbrar K Thabit, Ebtihal M Fairaq, Fahdah S Almutairi
Antimicrobial Agents and Chemotherapy|June 30, 2016
Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In VivoAbrar K Thabit, Marguerite L Monogue, David P Nicolau
International Journal of Nursing Practice|February 16, 2026
Impact of Sleep Quality on Work Functioning Among Critical Care Nurses at an Academic Tertiary HospitalHaneen M Almotary, Waleed M Kattan, Abrar K Thabit
International Journal of Antimicrobial Agents|October 16, 2016
Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogensAbrar K Thabit, Jared L Crandon, David P Nicolau
Antimicrobial Agents and Chemotherapy|October 21, 2015
In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin ExposureAbrar K Thabit, David P Nicolau, Joseph L Kuti
Antimicrobial Agents and Chemotherapy|June 30, 2016
Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative OrganismsMarguerite L Monogue, Abrar K Thabit, Yukihiro Hamada, et al.
Gut Pathogens|June 6, 2022
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?Eman T Azab, Abrar K Thabit, Sean McKee, et al.
European Journal of Clinical Pharmacology|January 11, 2023
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing EnterobacteralesMarwah H Barnawi, Abrar K Thabit, Diena M Almasri, et al.
Journal of Pharmacy Practice|November 11, 2017
Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal FunctionAbrar K Thabit, Mordechai Grupper, David P Nicolau, et al.
Pageof 9